Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,228 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of zonisamide on sleep and rapid eye movement sleep behavioral disorders in patients with Parkinson's disease: A randomized control trial.
Kataoka H, Isogawa M, Nanaura H, Kurakami H, Hasebe M, Kinugawa K, Kiriyama T, Izumi T, Kasahara M, Sugie K. Kataoka H, et al. Among authors: kasahara m. Clin Park Relat Disord. 2024 Nov 22;11:100285. doi: 10.1016/j.prdoa.2024.100285. eCollection 2024. Clin Park Relat Disord. 2024. PMID: 39650051 Free PMC article.
Cepharanthine and Oral Lichen Planus Efficacy (COLE) study: protocol for a multicentre randomised controlled study assessing the efficacy and safety of cepharanthine with topical corticosteroids in oral lichen planus.
Yagyuu T, Isogawa M, Yamamoto K, Sugiura T, Matsusue Y, Kasahara M, Kirita T. Yagyuu T, et al. Among authors: kasahara m. BMJ Open. 2023 Aug 16;13(8):e074279. doi: 10.1136/bmjopen-2023-074279. BMJ Open. 2023. PMID: 37586860 Free PMC article.
The clinical trial of alternative relugolix administration for uterine leiomyoma prior to surgically treatment: a study protocol for Non-Adverse Relugolix Administration (NARA) trial.
Kawahara N, Kawaguchi R, Yamamoto K, Nishikawa K, Matsuoka M, Maehana T, Fukui Y, Yamanaka S, Sugimoto S, Iwai K, Yamada Y, Kurakami H, Hirata T, Takashima R, Suzuki S, Asada K, Kasahara M, Kimura F. Kawahara N, et al. Among authors: kasahara m. Trials. 2024 Jan 19;25(1):68. doi: 10.1186/s13063-024-07923-2. Trials. 2024. PMID: 38243317 Free PMC article.
Comparison of canagliflozin and teneligliptin on energy intake and body weight in Japanese patients with Type 2 diabetes: a subanalysis of the CANTABILE study.
Isogawa M, Makino H, Son C, Nishimura K, Hirata T, Kasama S, Miyamoto Y, Noguchi M, Kasahara M, Hosoda K. Isogawa M, et al. Among authors: kasahara m. BMC Endocr Disord. 2024 Aug 19;24(1):153. doi: 10.1186/s12902-024-01690-6. BMC Endocr Disord. 2024. PMID: 39160513 Free PMC article. Clinical Trial.
Study protocol for assessment of the coagulation potential of concomitantly used factor VIII concentrates in patients with haemophilia A with emicizumab prophylaxis (CAGUYAMA Study): a multicentre open-label non-randomised clinical trial.
Takeyama M, Ozu N, Kasama S, Kasahara M, Matsumoto M, Shima M, Nogami K. Takeyama M, et al. Among authors: kasahara m. BMJ Open. 2023 Jul 10;13(7):e072565. doi: 10.1136/bmjopen-2023-072565. BMJ Open. 2023. PMID: 37429679 Free PMC article. Clinical Trial.
Rationale and design of the NEO-NORMAL-AF study examination of the usefulness of implantable loop recorder for arrhythmia detection including atrial fibrillation in heart failure with non-reduced ejection fraction cases: a pilot study.
Sugiura J, Kasama S, Ueda T, Nishida T, Kawata H, Horii M, Ozu N, Kasahara M, Saito Y. Sugiura J, et al. Among authors: kasahara m. Open Heart. 2023 Jul;10(2):e002193. doi: 10.1136/openhrt-2022-002193. Open Heart. 2023. PMID: 37507149 Free PMC article. Clinical Trial.
Novel pathological implications of serum uric acid with cardiovascular disease risk in obesity.
Wakabayashi D, Kato S, Tanaka M, Yamakage H, Kato H, Kusakabe T, Ozu N, Kasama S, Kasahara M, Satoh-Asahara N; Japan Obesity Metabolic Syndrome Study (JOMS) Group. Wakabayashi D, et al. Among authors: kasahara m. Diabetes Res Clin Pract. 2023 Nov;205:110919. doi: 10.1016/j.diabres.2023.110919. Epub 2023 Sep 22. Diabetes Res Clin Pract. 2023. PMID: 37742802
Effects of paroxetine, a P2X4 inhibitor, on cerebral aneurysm growth and recanalization after coil embolization: the NHO Drug for Aneurysm Study.
Fukuda S, Niwa Y, Ren N, Yonemoto N, Kasahara M, Yasaka M, Ezura M, Asai T, Miyazono M, Korai M, Tsutsumi K, Shigeta K, Oi Y, Nishimura A, Fukuda H, Goto M, Yoshida T, Fukuda M, Yasoda A, Iihara K. Fukuda S, et al. Among authors: kasahara m. J Neurosurg. 2024 Oct 25:1-8. doi: 10.3171/2024.6.JNS24714. Online ahead of print. J Neurosurg. 2024. PMID: 39454214
Assessment of global coagulation function under treatment with emicizumab concomitantly with bypassing agents in haemophilia A with inhibitor (UNEBI Study): multicentre open-label non-randomised clinical trial.
Ogiwara K, Taki M, Suzuki T, Takedani H, Matsushita T, Amano K, Matsumoto M, Nishio K, Shima M, Kasahara M, Nogami K. Ogiwara K, et al. Among authors: kasahara m. BMJ Open. 2022 Feb 17;12(2):e056922. doi: 10.1136/bmjopen-2021-056922. BMJ Open. 2022. PMID: 35177463 Free PMC article. Clinical Trial.
1,228 results